CRO

Parexel eyes Dublin for new hub; India goes to bat for GVK;

> Parexel International ($PRXL) is plotting a new corporate hub in Dublin, adding up to 130 positions to staff the operation. News

> India is putting off trade discussions with the European Union in response to the continent's ban of more than 700 drugs with ties to the data scandal at Indian CRO GVK BioSciences. Story

> PRA Health Sciences ($PRAH) is expanding its eClinical operation with a $2.5 million deal for Value Health Solutions. Item